A Study in Healthy Subjects to Assess Bioavailability (Proportion of a Drug Which Enters the Circulation to Have an Active Effect) of Acalabrutinib Tablet and Protonpump Inhibitor Effect (Members of a Class of Medications That Inhibits in Gastric Acid Production) for Rabeprazole
Clinical trial NCT04564040 · COMPLETED
Trial details
- NCT number
- NCT04564040
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-12
- Primary completion
- 2020-12-11
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.